跳至主要内容
临床试验/EUCTR2020-001678-31-FR
EUCTR2020-001678-31-FR进行中(未招募)1 期

Randomized controlled trial evaluating the efficacy of vaccination with Bacillus Calmette and Guérin (BCG) in the Prevention of COVID-19 via the strengthening of innate immunity in Health Care Workers.”COVID-BCG - COVID BCG

Assistance Publique Hopitaux de Paris0 个研究点目标入组 1,120 人开始时间: 2020年4月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
1,120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Individual (Male and female) aged 18 or over.
  • -Healthcare Worker (medical or non-medical) from hospitals in direct -contact with COVID-19 patients.
  • -Participants must give their written consent before any trial procedure.
  • -Participants covered by social security regimen (excepting AME).
  • -Healthy according to the opinion of the investigator.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Has any BCG vaccine contraindication, known allergy to the BCG vaccine or SAE to prior BCG vaccination.
  • -History of tuberculosis
  • -People with acquired or innate immunodeficiency.
  • -People have already been infected with SARS Cov-2 (virological documentation or TDM or seropositive if serology available).
  • -People who could not commit to follow-up for 6 months.
  • -People not in good general condition, as assessed by the investigator.
  • -People included in other therapeutic clinical trials assessing treatment
  • -Pregnant or breastfeeding at enrolment visit.
  • -BCG vaccine given within the last year.
  • -Another live vaccine administered in the month prior to randomization.
  • -History of anaphylaxis following vaccination.
  • -Receiving medical treatment that affects the immune response or other immunosuppressive therapy in the last year. These therapies include systemic corticosteroids (more than or equal to 10 mg for more than or equal to 2 weeks), immunosuppressant, biological agents (such as monoclonal antibodies against tumour necrosis factor (TNF)-alpha).
  • -Another vaccine administered in the month prior to inclusion and randomization.
  • - Fever > 38°C within the past 24 hours
  • - People under legal protection measure (tutorship)

研究者

相似试验